Position in UTHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$489,935,489
-$134,572,346 QoQ
Shares Held
826,226
-35.5% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.44380351138793.ToString("F0")%
Shared 0.ToString("F0")%
None 6.556196488612074.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (32.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $489,935,489 | 826,226 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $624,507,835 | 1,281,699 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $413,541,441 | 986,478 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $365,842,811 | 1,273,161 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $280,047,263 | 908,448 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $344,175,658 | 975,444 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $346,787,477 | 967,734 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $229,199,909 | 719,510 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $194,562,501 | 846,955 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $121,328,045 | 551,767 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $107,646,930 | 476,588 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $112,715,170 | 510,601 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $83,587,023 | 373,223 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $72,305,902 | 260,009 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $61,576,145 | 294,088 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,199,299 | 353,078 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $67,528,309 | 376,391 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $86,871,938 | 402,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $83,357,619 | 451,607 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $90,921,040 | 506,778 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $104,922,951 | 627,267 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $94,746,710 | 624,196 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $95,248,050 | 943,050 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $112,756,512 | 931,872 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $82,910,437 | 874,306 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||